VOLUME 2.4 ISSUE

PALL Kleenpak™ TFF MF Capsule

Pall Kleenpak TFF MF Capsule
PALL Kleenpak™ TFF MF Capsule

Introducing the Kleenpak™ TFF MF Capsule from PALL, a novel single-use, cost-effective solution for cell harvest or clarification. Kleenpak™ TFF MF Capsule represents Pall’s most recent innovation in the TFF product portfolio and is developed to meet the market demand in the fast growing single use filtration field. The product combines our proprietary Supor© membrane, proven Kleenpak™ format, and extensive TFF knowledge into one compact, economical, and efficient TFF module.

Kleenpak™ TFF MF consists of our Ultipleat© Supor polyethersulfone membrane with effective filtration area of 0.57m2. The product is designed to provide high flux and low protein adsorption that ensures high product transmission and maximum product recovery. Two pore sizes 0.20μm and 0.65μm are commercially available and customers can choose the most effective pore size to match their cell types, viability, and application.

The capsules can be manifolded in series, in parallel or in combination to increase the effective filtration area and such assembly can typically process batch sizes of 1000 liters or higher. Kleenpak™ TFF MF Capsules are made of Class VI materials with low extractable. The products can be autoclaved for sterilization or chemically sanitized with caustic solutions.

Features and Benefits:

  • Single use – no cleaning or cleaning validation
  • Supplied dry – no need to flush out storage agents
  • Encapsulated TFF – minimal capital investment
  • Manifoldable – scalability in 0.57 m2 increments
  • Sterilizable – can be autoclaved or chemically sanitized
  • Supor media - excellent retention and superb flow rate

Call your local RHFS Life Sciences field sales representative at 1.925.443.9800 for more information.


CPC's DrumQuik Pro Quick Disconnect Chemical Dispense System

CPC's DrumQuik® PRO Quick Disconnect Chemical Dispense System.

Call 1.800.848.1141 for more information.

News provided by Yahoo.com
ImaSight top execs buy shares in merged company (Ottawa Business Journal)
Fri, 04 Jul 2008 20:44:37 GMT
ImaSight insiders John Brooks and Jean Caseault have bought common shares of their newly public company as part of a reverse takeover deal with biopharmaceutical company Liponex Inc.
Alimera Sciences registers for IPO (AP via Yahoo! Finance)
Thu, 03 Jul 2008 19:47:27 GMT
Alimera Sciences Inc., a biopharmaceutical company that specializes in treatments for eye diseases, plans an initial public offering of its common stock, according to a Securities and Exchange Commission filing.
Transition Therapeutics CFO adds president role (AP via Yahoo! Finance)
Thu, 03 Jul 2008 12:15:27 GMT
Biopharmaceutical company Transition Therapeutics Inc. said Thursday it named Chief Financial Officer Elie Farah to the additional role of president.
Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008 (PR Newswire via Yahoo! Finance)
Fri, 04 Jul 2008 11:00:00 GMT
Shire Limited , the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on Thursday 31 July 2008

A MESSAGE TO OUR CUSTOMERS

At Ryan Herco Flow Solutions, we strive to deliver prompt, reliable service at every opportunity. Flexible business systems help us meet specific customer requirements and apply them consistently. Our team is encouraged and empowered to assure your complete satisfaction. We are committed to being your distributor of choice for fluid process and high value filtration needs.

2007 RHFS

On the Road

Visit us at these upcoming shows IBC Life Sciences
Save 25% on Conference Regisitration - Learn More

IBC’s 5th Single-Use Applications for Biopharmaceutical Manufacturing
Hilton San Diego Resort
San Diego, California June 2-4 2008

THE RHFS PULSE is published quarterly to keep you informed on fluid flow innovations.
Life Sciences Editor
Chris Knese

cknese@rhfs.com

2007 Ryan Herco Flow Solutions. All rights reserved.